Davidson Kempner Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,230,749
Closed -$430M 241
2025
Q4
$430M Buy
+4,230,749
New +$340M 5.49% 3

Other funds holding EXAS

Davidson Kempner Capital Management's EXAS Position: Q1 2026 in Review

Davidson Kempner Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 4,230,749 shares — an estimated $430M sold.

Davidson Kempner Capital Management first reported a position in EXAS in Q4 2025 and held it in 1 quarter. The position peaked at $430M in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Davidson Kempner Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 4,230,749 Exact Sciences shares in Q1 2026, an estimated $430M.
  • Davidson Kempner Capital Management first reported a position in Exact Sciences in Q4 2025 and held it in 1 quarter.
  • Davidson Kempner Capital Management's Exact Sciences position peaked at $430M in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Davidson Kempner Capital Management's 13F filing for Q1 2026, filed 15 May 2026.